Pemafibrate Protects against Fatty Acid-Induced Nephropathy by Maintaining Renal Fatty Acid Metabolism

As classical agonists for peroxisomal proliferator-activated receptor alpha (PPARα), fibrates activate renal fatty acid metabolism (FAM) and provide renoprotection. However, fibrate prescription is limited in patients with kidney disease, since impaired urinary excretion of the drug causes serious a...

Descripción completa

Detalles Bibliográficos
Autores principales: Aomura, Daiki, Harada, Makoto, Yamada, Yosuke, Nakajima, Takero, Hashimoto, Koji, Tanaka, Naoki, Kamijo, Yuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230306/
https://www.ncbi.nlm.nih.gov/pubmed/34207854
http://dx.doi.org/10.3390/metabo11060372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230306/
https://www.ncbi.nlm.nih.gov/pubmed/34207854
http://dx.doi.org/10.3390/metabo11060372

Ejemplares similares